Skip NavigationSkip to Content
Return Return to Search Results

Immunotherapy reaches new milestones in cancer eradication

  1. Author:
    Kotlan, B.
    Umansky, V.
    Malyguine, A. M.
    Marincola, F. M.
    Shurin, M. R.

  2. Author Address

    [Kotlan, B] Natl Inst Oncol, Ctr Surg & Mol Tumor Pathol, Dept Mol Immunol & Toxicol, Budapest, Hungary. [Umansky, V] German Canc Res Ctr, Clin Cooperat Unit, D-69120 Heidelberg, Germany. [Malyguine, AM] NCI, Lab Cell Mediated Immun, SAIC Frederick, Frederick, MD 21702 USA. [Marincola, FM] NIH, Infect Dis & Immunogenet Sect IDIS, Dept Translat Med, Ctr Clin, Bethesda, MD 20892 USA. [Marincola, FM] NIH, Ctr Human Immunol, Bethesda, MD 20892 USA. [Shurin, MR] Univ Pittsburgh, Dept Pathol, Med Ctr, Pittsburgh, PA 15213 USA. [Shurin, MR] Univ Pittsburgh, Dept Immunol, Med Ctr, Pittsburgh, PA 15213 USA.;Kotlan, B (reprint author), Natl Inst Oncol, Ctr Surg & Mol Tumor Pathol, Dept Mol Immunol & Toxicol, 1122 Rath Gy St 7-9, Budapest, Hungary;kotlanb@netscape.net
    1. Year: 2011
    2. Date: Oct
  2. Journal: Immunotherapy
    1. 3
    2. 10
    3. Pages: 1131-1137
  4. Type of Article: News Item
  5. ISSN: 1750-743X
  1. Keywords:

External Sources

  1. View Full Text
  2. DOI: 10.2217/imt.11.114
  3. View record in Web of Science®
  4. WOS: 000296711800004

Library Notes

  1. Fiscal Year: FY2011-2012
NCI at Frederick

You are leaving a government website.

This external link provides additional information that is consistent with the intended purpose of this site. The government cannot attest to the accuracy of a non-federal site.

Linking to a non-federal site does not constitute an endorsement by this institution or any of its employees of the sponsors or the information and products presented on the site. You will be subject to the destination site's privacy policy when you follow the link.

ContinueCancel